CERTUS technology is covered by an exclusive license from BD (Becton Dickinson) to commercialize the proprietary technology in the field of food safety. BD acquired the SERS nanoparticle technology due to its value as a platform system that can be applied to many kinds of diagnostic applications. BD further developed and patented the technology to enable detection in a bio-contained tube during enrichment so that the lab or plant where the testing is conducted is not exposed to enriched pathogens.
BD has now out-licensed the technology to CERTUS in an effort to focus on clinical applications of the technology. BD continues to support the CERTUS technology as the supplier of the proprietary SERS nanoparticles.